Acrolein generation stimulates hypercontraction in isolated human blood vessels

https://doi.org/10.1016/j.taap.2006.09.009Get rights and content

Abstract

Increased risk of vasospasm, a spontaneous hyperconstriction, is associated with atherosclerosis, cigarette smoking, and hypertension—all conditions involving oxidative stress, lipid peroxidation, and inflammation. To test the role of the lipid peroxidation- and inflammation-derived aldehyde, acrolein, in human vasospasm, we developed an ex vivo model using human coronary artery bypass graft (CABG) blood vessels and a demonstrated acrolein precursor, allylamine. Allylamine induces hypercontraction in isolated rat coronary artery in a semicarbazide-sensitive amine oxidase activity (SSAO) dependent manner. Isolated human CABG blood vessels (internal mammary artery, radial artery, saphenous vein) were used to determine: (1) vessel responses and sensitivity to acrolein, allylamine, and H2O2 exposure (1 μM–1 mM), (2) SSAO dependence of allylamine-induced effects using SSAO inhibitors (semicarbazide, 1 mM; MDL 72274-E, active isomer; MDL 72274-Z, inactive isomer; 100 μM), (3) the vasoactive effects of two other SSAO amine substrates, benzylamine and methylamine, and (4) the contribution of extracellular Ca2+ to hypercontraction. Acrolein or allylamine but not H2O2, benzylamine, or methylamine stimulated spontaneous and pharmacologically intractable hypercontraction in CABG blood vessels that was similar to clinical vasospasm. Allylamine-induced hypercontraction and blood vessel SSAO activity were abolished by pretreatment with semicarbazide or MDL 72274-E but not by MDL 72274-Z. Allylamine-induced hypercontraction also was significantly attenuated in Ca2+-free buffer. In isolated aorta of spontaneously hypertensive rat, allylamine-induced an SSAO-dependent contraction and enhanced norepinephrine sensitivity but not in Sprague–Dawley rat aorta. We conclude that acrolein generation in the blood vessel wall increases human susceptibility to vasospasm, an event that is enhanced in hypertension.

Introduction

Lipid peroxidation and inflammation can generate acrolein, a highly reactive α,β-unsaturated aldehyde. Oxidation of unsaturated fatty acids of lipoproteins and lipids forms alkoxyl and peroxyl radicals that decompose into several metastable carbonyl end products including acrolein (Grosch, 1987, Porter et al., 1995). Several disease states are associated with enhanced lipid peroxidation that lead to the accumulation of acrolein and acrolein–protein and acrolein–DNA adducts. Increased levels of acrolein have been measured in plasma of patients with renal failure (Sakata et al., 2003) and in Alzheimer's disease brain tissues (Lovell et al., 2001). Moreover, increased acrolein–protein adducts have been detected in vascular tissues of patients with diabetes (Daimon et al., 2003, Uesugi et al., 2004), Alzheimer's disease (Calingasan et al., 1999, Lovell et al., 2001), and atherosclerosis (Uchida, 1999, Uchida et al., 1998, Shao et al., 2005). Acrolein is also formed by myeloperoxidase-mediated oxidation of l-threonine, and thus activated neutrophils may contribute to vascular damage at sites of inflammation (Anderson et al., 1997). Other sources of tissue acrolein include glucose autoxidation-mediated oxidation of fatty acids (Medina-Navarro et al., 2004) and the oxidation of polyamines by amine oxidase (Gahl and Pitot, 1982), which is linked to polyamine-induced phase 2 enzymes (Kwak et al., 2003) and cytotoxicity (Sharmin et al., 2001).

Acrolein is also generated during metabolism of drugs and toxins. Metabolism of cyclophosphamide produces acrolein, which is implicated in the toxic action of the drug (i.e., hemorrhagic cystitis) (Kehrer and Biswal, 2000, Ren et al., 1999). Acrolein is formed in metabolism of allylamine (AA; an aliphatic amine used in the dye industry) by semicarbazide-sensitive amine oxidase (SSAO; EC 1.4.3.6; Boor and Nelson, 1982). Acute exposure of rats to AA in vivo causes SSAO-dependent subendocardial necrosis (Boor et al., 1979, Boor and Hysmith, 1987), and limited in vitro data indicate that this may result from coronary artery vasospasm (Conklin et al., 2001, Conklin and Boor, 1998). Thus, increased acrolein generation in the vascular wall from AA or other sources may well lead to vascular instability, altered vasoreactivity, and vasospasm.

Several diseases are associated with enhanced vascular inflammation, oxidative stress, and increased formation of acrolein and acrolein adducts in the blood vessel wall (Uchida et al., 1998). However, the effects of acrolein generation and accrual on vascular reactivity in human blood vessels are unknown. In a study of isolated rat coronary artery, we showed that direct acrolein exposure induces vasospasm-like effects and we validated the use of AA as an “acrolein generator” by showing that AA evokes SSAO-dependent effects similar to those of acrolein alone (Conklin et al., 2001, Conklin and Boor, 1998). Moreover, we confirmed the presence of a relatively high level of SSAO activity in human coronary arteries and coronary artery bypass graft (CABG) blood vessels that mediate methylamine-induced relaxation in CABG blood vessels (Conklin et al., 2001, Conklin et al., 2004). Thus, to simulate increased vascular production of acrolein associated with inflammation and lipid peroxidation and determine if acrolein generation promotes vasospasm in human blood vessels, we tested the direct effects of the acrolein generator AA. Herein we show that acrolein formation initiates hypercontraction via a calcium overload mechanism in human CABG blood vessels.

Section snippets

Human subjects

Adults (age years, mean ± SE, all, 62.8 ± 1.8; males, 59.9 ± 2.4, ≈ 77% of total; females, 71.9 ± 1.9; Table 1) undergoing CABG surgery at Luther Hospital/Midelfort Clinic (Eau Claire, WI) were the source of blood vessels. Unused sections of internal mammary artery (IMA), radial artery (RA), and saphenous vein (SV) were placed in lactated Ringers and refrigerated (4 °C) at the hospital. Vessels were retrieved between 4 and 16 h after surgery, cleaned of blood, staples, thread, and extraneous tissue, and

Acrolein generator AA induces hypercontraction in human blood vessels

AA pretreatment suppressed NE-induced tension in uncontracted vessels (data not shown), but in NE-precontracted CABG rings, 1 mM AA generally induced: (1) a triphasic response consisting of rapid and small contraction, sustained and robust relaxation, and spontaneous hypercontraction, (2) rapid inhibition of ACh- or SNP-induced relaxation, (3) sustained and elevated residual tension, and (4) a reduction in tension of HI K+-induced contraction (Fig. 1). Typically the onset of 1 mM AA-induced

Discussion

For many years, it has been proposed that reactive aldehydes as products of lipid peroxidation and inflammation contribute to progressive and deleterious changes in the hypertensive and atherosclerotic blood vessel wall (Shao et al., 2005, Uchida, 1999, Uchida et al., 1998, Anderson et al., 1997). In this study, we support this hypothesis in two specific ways: (1) real-time generation of acrolein in the blood vessel wall stimulates hypercontraction and (2) hypertension increases susceptibility

Acknowledgments

This work was supported by NIH Grant HL65416 (PJB), NIEHS AREA Grant 1R15 ES011141-01 (DJC), NIEHS 1P01 ES11860 (AB) NIEHS ES12062 (AB), NIH Grant GM48812 (LMS), and the University of Wisconsin-Eau Claire (UWEC) Office of Research and Sponsored Programs Student/Faculty Collaboration Grants, Summer Research Experience, University Research Creative Activity award (DJC), and the Ronald McNair Scholars Program at UWEC. We thank L. Eveland, M. Garney, D. Kranig, M. Phillips, E. Sackett, D.

References (61)

  • G.W. He

    Arterial grafts for coronary surgery: vasospasm and patency rate

    J. Thorac. Cardiovasc. Surg.

    (2001)
  • J.M. Hyvelin et al.

    Cellular mechanisms of acrolein-induced alteration in calcium signaling in airway smooth muscle

    Toxicol. Appl. Pharmacol.

    (2000)
  • C. Karasu

    Increased activity of H2O2 in aorta isolated from chronically streptozotocin-diabetic rats: effects of antioxidant enzymes and enzymes inhibitors

    Free Radical Biol. Med.

    (1999)
  • J. Kim et al.

    Inactivation of bovine plasma amine oxidase by haloallylamines

    Bioorg. Med. Chem.

    (2006)
  • M.K. Kwak et al.

    Induction of phase 2 enzymes by serum oxidized polyamines through activation of Nrf2: effect of the polyamine metabolite acrolein

    Biochem. Biophys. Res. Commun.

    (2003)
  • R. Lewinsohn et al.

    A benzylamine oxidase distinct from monoamine oxidase B-widespread distribution in man and rat

    Biochem. Pharmacol.

    (1978)
  • M.A. Lovell et al.

    Acrolein is increased in Alzheimer's disease brain and is toxic to primary hippocampal cultures

    Neurobiol. Aging

    (2001)
  • T. Matoba et al.

    Hydrogen peroxide is an endothelium-derived hyperpolarizing factor in human mesenteric arteries

    Biochem. Biophys. Res. Commun.

    (2002)
  • M. Nakayama et al.

    T(− 786)  C mutation in the 5′-flanking region of the endothelial nitric oxide synthase gene is associated with myocardial infarction, especially without coronary organic stenosis

    Am. J. Cardiol.

    (2000)
  • A. Peters

    Particulate matter and heart disease: evidence from epidemiological studies

    Toxicol. Appl. Pharmacol.

    (2005)
  • J.E. Quillen et al.

    Acute effect of cigarette smoking on the coronary circulation: constriction of epicardial and resistance vessels

    J. Am. Coll. Cardiol.

    (1993)
  • K. Ramos et al.

    Allylamine-induced vascular toxicity in vitro: prevention by semicarbazide-sensitive amine oxidase inhibitors

    Toxicol. Appl. Pharmacol.

    (1988)
  • K. Sakata et al.

    Increase in putrescine, amine oxidase, and acrolein in plasma of renal failure patients

    Biochem. Biophys. Res. Commun.

    (2003)
  • M.R. Sarabu et al.

    Early postoperative spasm in left internal mammary artery bypass grafts

    Ann. Thorac. Surg.

    (1987)
  • S. Sharmin et al.

    Polyamine cytotoxicity in the presence of bovine serum amine oxidase

    Biochem. Biophys. Res. Commun.

    (2001)
  • S. Srivastava et al.

    Involvement of aldose reductase in the metabolism of atherogenic aldehydes

    Chem.-Biol. Interact.

    (2001)
  • K. Uchida

    Current status of acrolein as a lipid peroxidation product

    Trends Cardiovasc. Med.

    (1999)
  • N. Uesugi et al.

    Possible mechanism for medial smooth muscle cell injury in diabetic nephropathy: glycoxidation-mediated local complement activation

    Am. J. Kidney Dis.

    (2004)
  • M.M. Anderson et al.

    Human neutrophils employ the myeloperoxidase-hydrogen peroxide-chloride system to convert hydroxy-amino acids into glycolaldehyde, 2-hydroxypropanal, and acrolein. A mechanism for the generation of highly reactive alpha-hydroxy and alpha,beta-unsaturated aldehydes by phagocytes at sites of inflammation

    J. Clin. Invest.

    (1997)
  • M.N. Ashraf et al.

    Effect of smoking status on mortality and morbidity following coronary artery bypass surgery

    Thorac. Cardiovasc. Surg.

    (2004)
  • Cited by (41)

    • Food additive octyl gallate eliminates acrolein and inhibits bacterial growth in oil-rich food

      2022, Food Chemistry
      Citation Excerpt :

      ACR can cause oxidative, DNA, and mitochondrial damages and exacerbate cell apoptosis (Jiang et al., 2022). Accumulation of ACR in vivo has toxic effects on the respiratory (Ong, Henry, & Burcham, 2012), cardiovascular (Conklin et al., 2006), nervous (Liu et al., 2020), and digestive (Liu, et al., 2020) systems, which are associated with various diseases such as diabetes, atherosclerosis, cardiovascular disease, Alzheimer’s disease, and Parkinson’s disease (Ambaw, Zheng, Tambe, Strathearn, & Shi, 2018; Tsou et al., 2017). The United States Environmental Protection Agency (EPA) classified ACR as a high-priority air toxicant due to its high toxicity (Robert, Giffe, Jayme, & Raymond, 2017).

    • Acrolein but not its metabolite, 3-Hydroxypropylmercapturic acid (3HPMA), activates vascular transient receptor potential Ankyrin-1 (TRPA1): Physiological to toxicological implications

      2021, Toxicology and Applied Pharmacology
      Citation Excerpt :

      Perhaps low concentrations of acrolein may contribute to physiological increases in blood flow associated with postprandial hyperemia, flow-mediated dilation (FMD) as in ischemia/reperfusion, and in hyperemic responses to local injury/infection. However, high concentrations of acrolein irreversibly impair contractility and stimulate tension oscillations (spasms) in SMA as seen in other blood vessels (Conklin et al., 2001), and thus, too much acrolein may lead to pathological changes including vasospasm, vascular toxicity and atherosclerosis (Conklin et al., 2006; Srivastava et al., 2011). This continuum belies the importance of studying acrolein because acrolein exposures are many and varied including from foods, beverages, occupational settings (firefighters), and combustion-derived smoke, i.e., tobacco smoke, wildfires, etc.

    • Crotonaldehyde-induced vascular relaxation and toxicity: Role of endothelium and transient receptor potential ankyrin-1 (TRPA1)

      2020, Toxicology and Applied Pharmacology
      Citation Excerpt :

      Moreover, there are at least 2 mechanisms mediating the full relaxation of CR: 1) endothelium-based; and, 2) time-dependent, irreversible change in vascular smooth muscle cell (VSMC) contractile machinery, e.g., closure of VSMC calcium channels. Although the latter conclusion has limited experimental support, we infer it because contractility is significantly impaired after CR exposure (and even after removal); endothelial function is intact because ACh-induced relaxation is unaffected post-CR (no endothelium dysfunction); and, previous experience with similar vascular toxicity of acrolein led to findings consistent with a role of external calcium (Conklin et al., 2006). Cigarette smoke is a major source of exogenous CR (Goniewicz et al., 2017; Lorkiewicz et al., 2019) as well as other aldehydes.

    • Molecular mechanism involved in cyclophosphamide-induced cardiotoxicity: Old drug with a new vision

      2019, Life Sciences
      Citation Excerpt :

      Cyclophosphamide and their metabolites also form adducts with cardiomyocytes α-actin, cystiene, desmin, platelet activating factor-4 and myosin light chain kinase polypeptides leading to subsequent cardiotoxicity [25]. Studies have reported that the activation of MMP-9 disrupts the atherosclerotic plaque and causes coronary occlusion [245–247]. Myeloperoxidase is another key regulator responsible for alteration in left-ventricular contraction and cardiac remodeling [25].

    View all citing articles on Scopus
    View full text